Concentrix Corporation (NASDAQ:CNXC) Receives Average Rating of “Hold” from Analysts

Shares of Concentrix Corporation (NASDAQ:CNXC) have been assigned an average recommendation of “Hold” from the five brokerages that are presently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and three have issued a buy recommendation on the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $63.75.

A number of equities analysts have weighed in on CNXC shares. Weiss Ratings downgraded shares of Concentrix from a “hold (c-)” rating to a “sell (d)” rating in a research note on Thursday, January 29th. Robert W. Baird set a $52.00 price objective on shares of Concentrix in a research report on Wednesday, January 14th. Barrington Research reaffirmed an “outperform” rating and set a $62.00 price objective on shares of Concentrix in a report on Tuesday, March 17th. Finally, Wall Street Zen raised Concentrix from a “hold” rating to a “buy” rating in a research note on Saturday, February 14th.

Concentrix Price Performance

Concentrix stock opened at $31.52 on Monday. The business’s fifty day moving average is $35.74 and its two-hundred day moving average is $40.66. The company has a debt-to-equity ratio of 1.67, a quick ratio of 1.40 and a current ratio of 1.40. The firm has a market cap of $1.93 billion, a P/E ratio of -1.51, a P/E/G ratio of 0.33 and a beta of 0.50. Concentrix has a 52 week low of $29.35 and a 52 week high of $66.00.

Concentrix (NASDAQ:CNXC) last announced its earnings results on Tuesday, January 13th. The company reported $2.95 earnings per share for the quarter, beating analysts’ consensus estimates of $2.93 by $0.02. Concentrix had a positive return on equity of 16.91% and a negative net margin of 13.02%.The company had revenue of $2.55 billion during the quarter, compared to analyst estimates of $2.54 billion. During the same period last year, the company posted $3.26 earnings per share. The firm’s quarterly revenue was up 4.3% compared to the same quarter last year. Concentrix has set its Q1 2026 guidance at 2.570-2.690 EPS and its FY 2026 guidance at 11.480-12.070 EPS. Equities research analysts forecast that Concentrix will post 10.11 earnings per share for the current fiscal year.

Concentrix Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, February 10th. Investors of record on Friday, January 30th were given a $0.36 dividend. This represents a $1.44 dividend on an annualized basis and a yield of 4.6%. The ex-dividend date was Friday, January 30th. Concentrix’s dividend payout ratio (DPR) is presently -6.91%.

Insider Transactions at Concentrix

In other Concentrix news, CEO Christopher A. Caldwell bought 1,000 shares of Concentrix stock in a transaction dated Thursday, January 29th. The shares were bought at an average price of $37.07 per share, with a total value of $37,070.00. Following the purchase, the chief executive officer owned 362,075 shares of the company’s stock, valued at $13,422,120.25. This trade represents a 0.28% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Insiders own 0.90% of the company’s stock.

Institutional Investors Weigh In On Concentrix

Institutional investors and hedge funds have recently modified their holdings of the business. Royal Bank of Canada raised its position in shares of Concentrix by 9.5% in the 1st quarter. Royal Bank of Canada now owns 47,501 shares of the company’s stock valued at $2,643,000 after acquiring an additional 4,133 shares during the period. Goldman Sachs Group Inc. grew its holdings in Concentrix by 75.1% during the first quarter. Goldman Sachs Group Inc. now owns 423,287 shares of the company’s stock valued at $23,552,000 after purchasing an additional 181,546 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in Concentrix by 17.4% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 146,515 shares of the company’s stock valued at $8,152,000 after purchasing an additional 21,746 shares in the last quarter. Focus Partners Wealth bought a new stake in Concentrix in the first quarter valued at approximately $781,000. Finally, Geneos Wealth Management Inc. raised its holdings in Concentrix by 532.7% in the first quarter. Geneos Wealth Management Inc. now owns 620 shares of the company’s stock worth $34,000 after purchasing an additional 522 shares during the period. 90.34% of the stock is owned by institutional investors.

About Concentrix

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.